Outcomes remain highly uncertain and hinge on uptake, effectiveness, persistency, and any benefits beyond BMI reduction so insurers should monitor this fast-moving landscape and consider implications for trend assumptions, lapse/anti-selection risk, underwriting, and claims
The FDA has issued multiple rounds of warning letters to telehealth companies regarding marketing practices for compounded GLP-1 products
Companies including Biocon, Dr
Alongside abdominal pain and diarrhea, other signs that warrant medical attention include: Blood in stool Severe dehydration Sudden weight gain or loss Problems swallowing Constipation Bloating When seeking medical attention, a team of GI specialists, like at Oshi Health, may provide the most thorough diagnosis and treatment plan
coli and a decrease in the number of beneficial bacteria such as Lactobacillus and Bifidobacterium
Neither Noom nor Medvi currently integrate genetic pathway assessment into personalization